Day: September 12, 2022

UPDATE – Expanded Partnership Between Arteris and Arm to Accelerate Automotive Electronics

Written by Customer Service on September 12, 2022. Posted in Public Companies.

The collaboration will provide greater choice of integrated and optimized solutions with leading Arm processors and Arteris system IP CAMPBELL, Calif., Sept. 12, 2022 (GLOBE NEWSWIRE) — Arteris, Inc. (Nasdaq: AIP), a leading provider of system IP which accelerates system-on-chip (SoC) creation, today announced that it is expanding its partnership with Arm to help speed up automotive electronics innovation. This collaboration leverages leading-edge Arm® processors with Arteris system IP to enable autonomous driving, advanced driver assistance systems (ADAS), cockpit and infotainment, vision, radar and lidar, body and chassis control, and other automotive subsystems. The partnership delivers solutions that could hasten the path for customers to realize SoCs with high performance and power efficiency for complex and demanding safety-critical...

Clinical Trials Market to Reach Value of $80.53 Billion By 2028 | Contract Research Organization to Take up over 40% market Share

Written by Customer Service on September 12, 2022. Posted in Mergers And Acquisitions.

Global clinical trials market was valued at US$ 48.07 billion in 2021, and it is expected to reach a value of US$ 80.53 billion by 2028, at a CAGR of more than 5.9% over the forecast period (2022–2028). Westford, USA, Sept. 12, 2022 (GLOBE NEWSWIRE) — Global clinical trials market continues to play a vital role in the advancement of drugs, medical devices, and therapies for patients. The number of clinical trials conducted each year has been on the rise, and this trend is expected to continue. As of August 2022, there are over 427,018 clinical trials registered with ClinicalTrials.gov across 221 countries, a 7% increase from the 399000 trials registered in 2021. This increase is primarily due to an increase in Phase III and IV trials. The US is the hotspot for the global clinical trials market as the country accounted for over...

DNA Sequencing Market to Generate Revenue of $29.89 Billion By 2028 | Demand for DNA Sequencing to Increase 1200% if Per Genome Sequencing Goes Down to $100

Written by Customer Service on September 12, 2022. Posted in Mergers And Acquisitions.

Global DNA sequencing market size was valued at US$ 5.1 billion in 2021, and it is expected to reach a value of US$ 29.89 billion by 2028, at a CAGR of 17.9% over the forecast period (2022–2028). Westford, USA, Sept. 12, 2022 (GLOBE NEWSWIRE) — As the world becomes increasingly digitized, so too does the legality of DNA sequencing market. What once was considered a fringe practice is now bustling with high-tech firms and scientists alike, thanks to advancements in technology and biomedical research. With such a wide range of applications for DNA sequencing, it’s no surprise that the market for this service has exploded in recent years. This growth is expected to be driven predominantly by the increasing demand for early disease detection and personalized medicine. Widespread adoption of DNA sequencing market will drive a...

NuCana Presents Promising Data on NUC-7738 at the European Society of Medical Oncology (ESMO) Annual Meeting 2022

Written by Customer Service on September 12, 2022. Posted in Public Companies.

NUC-7738 Demonstrates Encouraging Anti-Tumor Activity and a Favorable Safety Profile Across a Variety of Solid Tumors NUC-7738 Monotherapy and Combination with Pembrolizumab to be Investigated in Phase 2 PARIS, Sept. 12, 2022 (GLOBE NEWSWIRE) — NuCana plc (NASDAQ: NCNA) announced data today from the ongoing NuTide:701 study of NUC-7738 in an oral presentation at the European Society for Medical Oncology (ESMO) Annual Meeting. Oral 455MO: NUC-7738 in Patients with Advanced Solid Tumors- Phase 1 results from the NuTide:701 Phase 1 / 2 Study Data on NUC-7738 from the Phase 1 part of NuTide:701 showed encouraging signals of anti-tumor activity across a range of tumor types, particularly melanoma. Promising data were observed in a variety of solid tumors with numerous patients staying on treatment for extended periods, including one...

PHI GROUP TO PARTICIPATE IN INFRASTRUCTURE PROJECTS IN VIETNAM

Written by Customer Service on September 12, 2022. Posted in Public Companies.

New York, Sept. 12, 2022 (GLOBE NEWSWIRE) — PHI Group, Inc. (n/k/a Philux Global Group Inc., www.philuxglobal.com, PHIL), a diversified holding company currently sponsoring PHILUX Global Funds (a group of Luxembourg bank funds), developing the Asia Diamond Exchange project (“ADE”) in Vietnam, engaging in mergers and acquisitions and investing in special situations (www.co2-1-0.io), is pleased to announce that the Company has been approved by the Department of Planning and Investment of Ho Chi Minh City, Vietnam for registration of investment participation in the construction of Ho Chi Minh City – Moc Bai Expressway project. Ho Chi Minh City – Moc Bai Expressway project will be deployed by Public-Private Partnership (PPP) scheme with Build-Operate-Transfer (BOT) contract, with total length of about 50 km, design speed of 120km/h,...

U.S. Global Investors Provides Update on September’s Monthly Stock Buyback and Dividend Programs

Written by Customer Service on September 12, 2022. Posted in Public Companies.

San Antonio, TX, Sept. 12, 2022 (GLOBE NEWSWIRE) — U.S. Global Investors, Inc. (NASDAQ: GROW) (the “Company”), a registered investment advisory firm with longstanding experience in global markets and specialized sectors, is pleased to provide an update on its monthly stock repurchase and dividend programs. Stock Repurchases Earlier this year, the Company announced that it increased the limit to its annual share buyback program, from $2.75 million to $5 million. The Company bought back 2,381 shares in August 2022, at a net cost of approximately $9,380, down from 4,330 shares repurchased in the same month a year earlier, at a net cost of nearly $26,530. The reason for the decrease in the number of repurchased shares is that the daily volatility was much less in August 2022 than it was a year ago. The Company strategically repurchases...

Davidson Kempner Capital Management LP : Form 8.3 – Davidson Kempner Capital Management LP

Written by Customer Service on September 12, 2022. Posted in Mergers And Acquisitions.

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION(a) Full name of discloser: Davidson Kempner Capital Management LP(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree Schneider Electric SE(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: (e) Date position held/dealing undertaken: For an opening...

Davidson Kempner Capital Management LP : Form 8.3 – Davidson Kempner Capital Management LP

Written by Customer Service on September 12, 2022. Posted in Mergers And Acquisitions.

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION(a) Full name of discloser: Davidson Kempner Capital Management LP(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree AVEVA Group plc(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: (e) Date position held/dealing undertaken: For an opening...

Form 8.3 – Octopus Investments – GB Group plc

Written by Customer Service on September 12, 2022. Posted in Mergers And Acquisitions.

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: OCTOPUS INVESTMENTS LTD(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree GB Group plc(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: (e) Date position held/dealing...

Global Event Management Software Market to Surpass Valuation of $14.8 Billion By 2028 | Cloud-based Event Management Software to Grow at CAGR of 19.2%

Written by Customer Service on September 12, 2022. Posted in Mergers And Acquisitions.

Global event management software market was valued at USD 5.90 billion in 2021 and it is expected to reach at USD 14.8 billion by 2028, with CAGR of 14.6% over the forecast period (2022–2028). Westford, Market, Sept. 12, 2022 (GLOBE NEWSWIRE) — Event Management Software Market is becoming increasingly popular as organizations seek to streamline their event planning and management processes. Today, businesses have recognized the value presented by these programs. Many people are now using these programs to organize events and manage the overall logistics of these gatherings. The main reasons for this growth are the increasing popularity of events and festivals, the uptick in large-scale events, and the growing need for efficient and effective event planning and execution. Apart from this, one of the key factors driving global event...

Day: September 12, 2022

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice